GAVI to Launch 18 Million Malaria Vaccine Doses in Africa

Gavi, the vaccine alliance, has announced that twelve African countries will receive 18 million doses of the world's first malaria vaccine over the next two years. Bharat Biotech and Serum Institute of India will manufacture the vaccines. Malaria is a leading cause of death in Africa, and these vaccines will play a critical role in saving lives. The vaccine supply will initially be limited, with priority given to areas with the highest risk of malaria illness and death among children. The vaccines will be introduced into routine immunization programs in these countries for the first time, starting in early 2024.